Efficacy of furosemide for prevention of volume overload in children with transfusion-dependent thalassemia at Phramongkutklao hospital

Phase 3

• Conditions: undrelying thalassemia who receive blood transfusion; transfusion, thalassemia, furosemide

• Registration Number: TCTR20180209001
• Lead Sponsor: phramongkutklao hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2018-02-09
• Study Completion: 2018-09-06
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending (Not yet recruiting)
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

1.age 1-25 yrs.
2.need transfusin dependent
3.parental permission

Exclusion Criteria

1.history of allergic to furosemide
2. history of heart failure
3.history of high blood pressure

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
T-proBNP 4 hrs ug/dl

Secondary Outcome Measures

Name	Time	Method
blood pressure 4 hrs mmhg